387078006: Spironolactone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Aldosterone receptor antagonist\Spironolactone (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Diuretic (substance)\Potassium-sparing diuretic (substance)\Aldosterone receptor antagonist\Spironolactone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Spironolactone (substance)	Is a	Potassium-sparing diuretic (substance)	false	Inferred relationship	Some
Spironolactone (substance)	Is a	Aldosterone receptor antagonist	true	Inferred relationship	Some
Spironolactone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Aldosterone receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Spironolactone measurement	Component	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone adverse reaction (disorder)	Causative agent (attribute)	True	Spironolactone (substance)	Inferred relationship	Some	1
Allergy to spironolactone	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 5mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 10mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 25mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 50mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone 25mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Furosemide 20 mg and spironolactone 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Product containing hydroflumethiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone and loop diuretic adverse reaction	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some	2
Spironolactone and thiazide diuretic adverse reaction	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some	2
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some
Allergy to spironolactone and thiazide diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone+loop diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Spironolactone+thiazide diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some
Product containing furosemide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing hydrochlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing chlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Administration of prophylactic spironolactone (procedure)	Direct substance	False	Spironolactone (substance)	Inferred relationship	Some	1
Administration of prophylactic spironolactone (procedure)	Direct substance	True	Spironolactone (substance)	Inferred relationship	Some	1
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some	1
Allergy to spironolactone	Causative agent (attribute)	True	Spironolactone (substance)	Inferred relationship	Some	1
Allergy to spironolactone and loop diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some	2
Allergy to spironolactone and thiazide diuretic	Causative agent (attribute)	False	Spironolactone (substance)	Inferred relationship	Some	2
Product containing spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 100 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Spironolactone (substance)	Inferred relationship	Some	2
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Spironolactone (substance)	Inferred relationship	Some	1
Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Spironolactone (substance)	Inferred relationship	Some	2
Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 10 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 10 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 1 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 1 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing hydrochlorothiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing furosemide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only chlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Product containing only hydrochlorothiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only hydroflumethiazide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only furosemide and spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only spironolactone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only furosemide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only hydrochlorothiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Product containing only hydroflumethiazide and spironolactone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	1
Furosemide 20 mg and spironolactone 50 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	1
Spironolactone 50 mg and torasemide 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	2
Spironolactone 50 mg and torasemide 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	2
Product containing spironolactone and torasemide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Product containing only spironolactone and torasemide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Product containing spironolactone and torasemide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Product containing only spironolactone and torasemide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Spironolactone (substance)	Inferred relationship	Some	2
Spironolactone 50 mg and torasemide 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Spironolactone (substance)	Inferred relationship	Some	2
Spironolactone 50 mg and torasemide 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Spironolactone (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461256018	Spironolactone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481192019	Spironolactone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
59051000195115	spironolattone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
841971000172115	spironolactone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
74321000195112	Spironolacton	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module